At an unprecedented time in history, with a rapidly ageing global population and a burgeoning diabetes epidemic, the Diabetic Retinopathy (DR) Barometer Study represents a body of work supported by thousands of adults with diabetes, health care professionals from many disciplines and hundreds of organisations and agencies working in the field of ageing, diabetes, and eye health.

To improve understanding of the complex global, regional and specific country issues giving rise to increased prevalence of DR and diabetic macular edema (DME), a comprehensive, two-phase, multi-country study was conducted in 41 countries around the world. This ground-breaking study shines a spotlight on the status of prevention, assessment, and treatment of diabetic eye diseases (DED), as well as the real-life experiences of people living with the condition and the perspectives of the clinicians they interact with.

This study contributes to meaningful evidence that builds an initial knowledge platform of influence to inform and shape vision-related policy.

About the DR Barometer Study

Patient Experiences of DR and DME
Share This